85 results
8-K
EX-10.1
RNLX
Renalytix Plc
12 Jun 24
Departure of Directors or Certain Officers
5:00pm
and that he will not be eligible for any employee benefits (nor does he desire any of them) and expressly waives any entitlement to such benefits. Consultant
424B5
RNLX
Renalytix Plc
15 May 24
Prospectus supplement for primary offering
10:09am
and maintain regulatory approvals for other products from our KidneyIntelX platform;
the potential benefits of KidneyIntelX;
the market opportunities … is eligible for the benefits of the Treaty and is:
a citizen or individual resident of the United States;
(ii)
a corporation, or other entity taxable
8-K
EX-1.1
RNLX
Renalytix Plc
15 May 24
Entry into a Material Definitive Agreement
9:23am
benefits, including stock option agreements under any stock option plan of the Company.
(y)Sarbanes Oxley Compliance. The Company … of other securities, pursuant to any employee or director stock option or benefits plan, stock ownership plan or dividend reinvestment plan (but not shares
8-K
EX-99.1
t3xvgk3
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
424B3
hcoccb6mslm k8gp
7 May 24
Prospectus supplement
6:29pm
8-K
p0jgs8gca3ps3
23 Apr 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.2
j54 kfo49jeqgdm
23 Apr 24
Entry into a Material Definitive Agreement
5:00pm
424B5
magsur
9 Apr 24
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.1
dccj92ng5
29 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.1
qlvb89hi5zwcrmgdz
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.1
z21 1brd7z8
15 Feb 24
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
7:00am
8-K
EX-99.1
kyeni dnbffsdhgy9omi
10 Jan 24
Regulation FD Disclosure
7:15am
10-Q
EX-10.2
qijpc7 ovw0b
14 Nov 23
Quarterly report
12:00am
10-Q
o5gm5ap8
14 Nov 23
Quarterly report
12:00am